Nature
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers - npj Breast Cancer
Endocrine therapy treatment was based on local guidelines. 715/6693 (10.7%) MINDACT patients had HR+, HER2-, T1abN0 breast cancer ...
4 days ago